NCT02653885

Brief Summary

The outcome predictors for cardiac surgery has been popular for many researchers and clinicians. Determining risk factors before surgery reduce morbidity and mortality after surgery. Some routine blood results have been used as predictors for cardiac surgery but none of the researches studied red cell distribution width, mean platelet volume, platelet/lymphocyte ratio and neutrophil/lymphocyte ratio. This study focused on these parameters and to see whether these parameters can be predictors for cardiac surgery.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 11, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 12, 2016

Completed
Last Updated

January 13, 2016

Status Verified

January 1, 2016

Enrollment Period

3.9 years

First QC Date

January 11, 2016

Last Update Submit

January 12, 2016

Conditions

Cardiac Disease

Keywords

cardiac surgeryopen heart surgeryhemogram

Outcome Measures

Primary Outcomes (1)

  • incidence of combined adverse effects

    48 hours

Interventions

Red red cell distribution widthOTHER

Results from hemogram

Also known as: Mean platelet volume, Platelet/lymphocyte ratio, Neutrophil/lymphocyte ratio

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

cardiac patients needed cardiac surgery

You may qualify if:

  • elective, on-pump cardiac surgery

You may not qualify if:

  • emergent cases
  • pediatric cases
  • congenital surgery
  • heart transplantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart Diseases

Interventions

Erythrocyte IndicesMean Platelet VolumePlatelet Count

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Intervention Hierarchy (Ancestors)

Hematologic TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesBlood Physiological PhenomenaCirculatory and Respiratory Physiological PhenomenaPlatelet Function TestsCell SizeCell Physiological PhenomenaBlood Cell CountCell CountCytological Techniques

Study Officials

  • CIGDEM YILDIRIM GUCLU, MD

    Ankara University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 11, 2016

First Posted

January 12, 2016

Study Start

January 1, 2011

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

January 13, 2016

Record last verified: 2016-01